JPMorgan Chase & Co. Sells 7,449 Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX)

JPMorgan Chase & Co. lessened its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 18.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,915 shares of the company’s stock after selling 7,449 shares during the period. JPMorgan Chase & Co. owned 0.06% of Nano-X Imaging worth $244,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of NNOX. Barclays PLC raised its position in shares of Nano-X Imaging by 258.5% during the third quarter. Barclays PLC now owns 86,181 shares of the company’s stock worth $523,000 after acquiring an additional 62,140 shares during the last quarter. ARK Investment Management LLC increased its position in Nano-X Imaging by 19.0% in the fourth quarter. ARK Investment Management LLC now owns 300,757 shares of the company’s stock worth $2,165,000 after purchasing an additional 48,124 shares during the period. Raymond James Financial Inc. bought a new stake in Nano-X Imaging during the 4th quarter worth about $251,000. SBI Securities Co. Ltd. acquired a new position in Nano-X Imaging during the 4th quarter valued at about $194,000. Finally, Wesbanco Bank Inc. bought a new position in shares of Nano-X Imaging in the 4th quarter valued at about $178,000. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Trading Up 3.2 %

Shares of NNOX opened at $5.15 on Friday. The stock has a market cap of $297.56 million, a P/E ratio of -6.06 and a beta of 2.03. Nano-X Imaging Ltd. has a 1 year low of $3.75 and a 1 year high of $11.00. The stock’s 50-day moving average price is $5.27 and its two-hundred day moving average price is $6.40.

Nano-X Imaging (NASDAQ:NNOX) last released its quarterly earnings data on Monday, March 31st. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. The firm had revenue of $3.00 million for the quarter, compared to the consensus estimate of $3.80 million. As a group, equities analysts forecast that Nano-X Imaging Ltd. will post -0.92 EPS for the current year.

Wall Street Analysts Forecast Growth

NNOX has been the subject of a number of recent research reports. D. Boral Capital reissued a “buy” rating and set a $15.00 price target on shares of Nano-X Imaging in a research note on Thursday, April 17th. Cantor Fitzgerald dropped their target price on shares of Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Tuesday, April 1st.

Nano-X Imaging Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.